Immunogenicity and protection efficacy of enhanced fitness recombinant Salmonella Typhi monovalent and bivalent vaccine strains against acute toxoplasmosis

References

• Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000;30(12–13):1217–1258.
   Google Scholar
• Dubey JP, Jones JL. Toxoplasma gondii infection in humans and animals in the United States. Int J Parasitol. 2008;38(11):1257–1278.
   Google Scholar
• Wang Z-D, et al. Prevalence and burden of Toxoplasma gondii infection in HIV-infected people: a systematic review and meta-analysis. Lancet HIV. 2018;4(4):e177–e188.
   Google Scholar
• Capobiango JD, Monica TC, Ferreira FP, et al. Evaluation of the Western blotting method for the diagnosis of congenital toxoplasmosis. J Pediatr (Rio J). 2016;92(6):616–623.
   Google Scholar
• de Barros JLVM, Barbosa IG, Salem H, et al. Is there any association between Toxoplasma gondii infection and bipolar disorder? A systematic review and meta-analysis. J Affect Disord. 2017;209:59–65.
   Google Scholar
• Sutterland AL, Fond G, Kuin A, et al. ‘Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis’. Acta Psychiatr Scand. 2015;132(3):161–179.
   Google Scholar
• Dunay IR, et al. Treatment of Toxoplasmosis: historical perspective, animal models, and current clinical practice. Clin Microbiol Rev. 2018. DOI:https://doi.org/10.1128/CMR.00057-17.
   Google Scholar
• Galen JE, et al. ‘Salmonella enterica serovar Typhi live vector vaccines finally come of age’. Immunol Cell Biol. 2009;87:400–412.
   Google Scholar
• Galen JE, Buskirk AD, Tennant SM, et al. Live attenuated human salmonella vaccine candidates: tracking the pathogen in natural infection and stimulation of host immunity. EcoSal Plus. 2016;7(1):1.
   Google Scholar
• Wang JY, Harley RH, Galen JE. Novel methods for expression of foreign antigens in live vector vaccines. Hum Vaccines Immunother. 2013;9(7):1558–1564.
   Google Scholar
• Galen JE, Wang JY, Carrasco JA, et al. A bivalent typhoid live vector vaccine expressing both chromosome- and plasmid-encoded Yersinia pestis antigens fully protects against murine lethal pulmonary plague infection. Infect Immun. 2015;83(1):161–172.
   Google Scholar
• Sanapala S, Rahav H, Patel H, et al. Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague. Vaccine. 2016;34(21):2410–2416.
   Google Scholar
• Li Q, Lv Y, Li Y-A, et al. Live attenuated Salmonella enterica serovar Choleraesuis vector delivering a conserved surface protein enolase induces high and broad protection against Streptococcus suis serotypes 2, 7, and 9 in mice. Vaccine. 2020;38(44):6904–6913.
   Google Scholar
• Li YA, Chen Y, Du YZ, et al. Live-attenuated Salmonella enterica serotype Choleraesuis vaccine with regulated delayed fur mutation confer protection against Streptococcus suis in mice. BMC Vet Res. 2020;16(1). DOI:https://doi.org/10.1186/s12917-020-02340-4
   Google Scholar
• Blader IJ, Coleman BI, Chen C-T, et al. ‘Lytic Cycle of Toxoplasma gondii: 15 Years Later. Annu Rev Microbiol. 2015;69(1):463–485.
   Google Scholar
• Weiss LM, Kim K. The development and biology of bradyzoites of Toxoplasma gondii. Front biosci j virtual lib. 2000;5(4):D391–D405.
   Google Scholar
• Pagheh AS, Sarvi S, Sharif M, et al. Toxoplasma gondii surface antigen 1 (SAG1) as a potential candidate to develop vaccine against toxoplasmosis: A systematic review. Comp Immunol Microbiol Infect Dis. 2020;69:101414.
   Google Scholar
• Rezaei F, Sharif M, Sarvi S, et al. A systematic review on the role of GRA proteins of Toxoplasma gondii in host immunization. J Microbiol Methods. 2019;165:105696.
   Google Scholar
• Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A. 2000;97(12):6640–6645.
   Google Scholar
• Cherepanov PP, Wackernagel W. Gene disruption in Escherichia coli: tcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene. 1995;158(1):9–14.
   Google Scholar
• Powell DA, Roberts LM, Ledvina HE, et al. Distinct innate responses are induced by attenuated Salmonella enterica serovar Typhimurium mutants. Cell Immunol. 2015;299:42–49.
   Google Scholar
• Loh FK, Nathan S, Chow S-C, et al. Vaccination challenges and strategies against long-lived Toxoplasma gondii. Vaccine. 2019;37(30):3989–4000.
   Google Scholar
• Ramirez K, Capozzo AVE, Lloyd SA, et al. ‘Mucosally delivered salmonella typhi expressing the yersinia pestis F1 antigen elicits mucosal and systemic immunity early in life and primes the neonatal immune system for a vigorous anamnestic response to parenteral F1 boost’. J Iimmunol. Baltimore, Md. : 1950. 2009;182(2):1211–1222.
   Google Scholar
• Crotty S, Aubert RD, Glidewell J, et al. Tracking human antigen-specific memory B cells: A sensitive and generalized ELISPOT system. J Immunol Methods. 2004;286(1–2):112–122.
   Google Scholar
• Cao A, Liu Y, Wang J, et al. Toxoplasma gondii: vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice. Vaccine. 2015;33(48):6757–6762.
   Google Scholar
• Allahyari M, Mohabati R, Amiri S, et al. Synergistic effect of rSAG1 and rGRA2 antigens formulated in PLGA microspheres in eliciting immune protection against Toxoplasama gondii. Exp Parasitol. 2016;170:236–246.
   Google Scholar
• Zhou H, Min J, Zhao Q, et al. Protective immune response against Toxoplasma gondii elicited by a recombinant DNA vaccine with a novel genetic adjuvant. Vaccine. 2012;30(10):1800–1806.
   Google Scholar
• Ravindran R, McSorley SJ. Tracking the dynamics of T-cell activation in response to Salmonella infection. Immunology. 2005;114(4):450–458.
   Google Scholar
• Butler T. Treatment of typhoid fever in the 21st century: promises and shortcomings. Clin Microbiol Infect. 2011;17(7):959–963.
   Google Scholar
• Pathangey L, Kohler JJ, Isoda R, et al. Effect of expression level on immune responses to recombinant oral Salmonella enterica serovar Typhimurium vaccines. Vaccine. 2009;27(20):2707–2711.
   Google Scholar
• Husnain SI, Thomas MS. The UP element is necessary but not sufficient for growth rate-dependent control of the Escherichia coli guaB promoter. J Bacteriol. 2008;190(7):2450–2457.
   Google Scholar
• Stokes MGM, Titball RW, Neeson BN, et al. Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis. Infect Immun. 2007;75(4):1827–1834.
   Google Scholar
• Huang W, Wang S, Yao Y, et al. Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection. Sci Rep. 2016;6(1):37242.
   Google Scholar
• Roderer D, Glockshuber R. ‘Assembly mechanism of the α-pore–forming toxin cytolysin A from Escherichia Coli’. Philos Trans R Soc B. 2017;372(1726):20160211.
   Google Scholar
• Sher A, Tosh K, Jankovic D. Innate recognition of Toxoplasma gondii in humans involves a mechanism distinct from that utilized by rodents. Cell Mol Immunol. 2016;1–7. February. DOI:https://doi.org/10.1038/cmi.2016.12.
   Google Scholar
• Bartolomucci A, Palanza P, Gaspani L, et al. Social status in mice: behavioral, endocrine and immune changes are context dependent. Physiol Behav. 2001;73(3):401–410.
   Google Scholar
• Galen JE, et al. Mucosal immunization with attenuated Salmonella enterica serovar Typhi expressing protective antigen of anthrax toxin (PA83) primes monkeys for accelerated serum antibody responses to parenteral PA83 vaccine. J Infect Dis. 2009;199(3):326–335.
   Google Scholar
• Han Y, Zhou A, Lu G, et al. Protection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB/c mice. BMC Infect Dis. 2017;17(1):59.
   Google Scholar
• Lu G, Wang L, Zhou A, et al. Epitope analysis, expression and protection of SAG5A vaccine against Toxoplasma gondii. Acta Trop. 2015;146:66–72.
   Google Scholar
• Pagheh AS, Sarvi S, Gholami S, et al. Protective efficacy induced by DNA prime and recombinant protein boost vaccination with Toxoplasma gondii GRA14 in mice. Microb Pathog. 2019;134:103601.
   Google Scholar
• HogenEsch H, O’Hagan DT, Fox CB. Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want. Npj Vaccines. 2018;3(1). DOI:https://doi.org/10.1038/s41541-018-0089-x
   Google Scholar
• Bueno SM, Riquelme S, Riedel CA, et al. Mechanisms used by virulent Salmonella to impair dendritic cell function and evade adaptive immunity. Immunology. 2012;137(1):28–36.
   Google Scholar
• Lazarski CA, Chaves FA, Jenks SA, et al. The kinetic stability of MHC class II: Peptide complexes is a key parameter that dictates immunodominance. Immunity. 2005;23(1):29–40.
   Google Scholar
• Sant AJ, Chaves FA, Leddon SA, et al. The control of the specificity of CD4 T cell responses: thresholds, breakpoints, and ceilings. Front Immunol. 2013;4. DOI:https://doi.org/10.3389/fimmu.2013.00340.
   Google Scholar
• Sasai M, Pradipta A, Yamamoto M. Host immune responses to Toxoplasma gondii. Int Immunol. 2018;30(3):113–119.
   Google Scholar
• Zhou W, Zhang F, Aune TM. Either IL-2 or IL-12 is sufficient to direct Th1 differentiation by nonobese diabetic T cells. J Immunol. 2003;170(2):735–740.
   Google Scholar
• Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol. 2008;180(9):5771–5777.
   Google Scholar
• Dimier-Poisson I, Aline F, Mévélec M-N, et al. Protective mucosal Th2 immune response against Toxoplasma gondii by murine mesenteric lymph node dendritic cells. Infect Immun. 2003;71(9):5254–5265.
   Google Scholar
• Dogruman-Al F, Fidan I, Celebi B, et al. Cytokine profile in murine toxoplasmosis. Asian Pac J Trop Med. 2011;4(1):16–19.
   Google Scholar
• Li X, Lv L, Zhang X, et al. Recombinant canine adenovirus type-2 expressing TgROP16 provides partial protection against acute Toxoplasma gondii infection in mice. Infect Genet Evol. 2016;45:447–453.
   Google Scholar
• Wang H-L, Wen L-M, Pei Y-J, et al. ‘Recombinant Toxoplasma gondii phosphoglycerate mutase 2 confers protective immunity against toxoplasmosis in BALB/c mice’. Parasite. 2016;23:12.
   Google Scholar
• Gavrilescu LC, Denkers EY. IFN-γ overproduction and high level apoptosis are associated with high but not low virulence Toxoplasma gondii infection. J Immunol. 2001;167(2):902–909.
   Google Scholar
• Mordue DG, Monroy F, La Regina M, et al. Acute Toxoplasmosis leads to lethal overproduction of Th1 cytokines. J Immunol. 2001;167(8):4574–4584.
   Google Scholar
• Sayles PC, Gibson GW, Johnson LL. B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii. Infect Immun. 2000;68(3):1026–1033.
   Google Scholar
• Golkar M, Shokrgozar M-A, Rafati S, et al. Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice. Vaccine. 2007;25(21):4301–4311.
   Google Scholar
• Siachoque H, Guzman F, Burgos J, et al. Toxoplasma gondii: immunogenicity and protection by P30 peptides in a murine model. Exp Parasitol. 2006;114(1):62–65.
   Google Scholar
• Sallusto F, Lanzavecchia A, Araki K, et al. From vaccines to memory and back. Immunity. 2010;33(4):451–463.
   Google Scholar
• Joffre OP, Segura E, Savina A, et al. Cross-presentation by dendritic cells. Nat Rev Immunol. 2012;12(8):557–569.
   Google Scholar
• Pennock ND, White JT, Cross EW, et al. T cell responses: naïve to memory and everything in between. Adv Physiol Educ. 2013;37(4):273–283.
   Google Scholar
• Roberts AD, Ely KH, Woodland DL. Differential contributions of central and effector memory T cells to recall responses. J Exp Med. 2005;202(1):123–133.
   Google Scholar
• Skibinski DA, et al. Combination vaccines. J Glob Infect Dis. 2011;3(1):63–72.
   Google Scholar
• Yang D, Liu J, Hao P, et al. MIC3, a novel cross-protective antigen expressed in Toxoplasma gondii and Neospora caninum. Parasitol Res. 2015;114(10):3791–3799.
   Google Scholar